Opendata, web and dolomites


A rapid, low-cost, cervical cancer screening platform

Total Cost €


EC-Contrib. €






Project "HoloCyt" data sheet

The following table provides information about the project.


Organization address
address: RUE DU BOURDON 100
postcode: 1180
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2017-06-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OVIZIO IMAGING SYSTEMS BE (BRUXELLES) coordinator 50˙000.00


 Project objective

Cervical cancer causes 13.000 deaths and 34.000 new cases in the European Union. 200M tests are performed worldwide per year representing a $3,4B market.

Today two tests are performed to diagnose cervical cancer. Firstly, a cervical smear is analysed by a pathologist via a visual subjective inspection using traditional microscopy. This is an 8-step process performed by several persons at different locations. Secondly, if positive, a molecular 4-step HPV test is performed. Results are available after 3 to 4 weeks causing anxiety and frustration for the patient. Typical instruments are expensive and have high related operational costs.

Ovizio has designed a direct read vial allowing for the sample to be directly analysed without manipulation. The technology automatically generates objective data, identifying cells, detecting malicious cells and combines cytology and HPV in one test. This is a 3-step process: 1. sampling, 2. analysing, 3. report generation. The test is performed on a small low-cost device giving results in minutes rather than days allowing for near patient testing.

A proof of concept and alpha prototype have been built with basic software algorithms. Several test have been performed at hospitals in Belgium and France resulting in two scientific publications and enthusiasm from key opinion leaders.

The breakthrough technology transforms microscopic images into actionable data, corresponding to a market need of faster and improved testing, allowing healthcare organisations of member states to reduce costs and improve testing ratio’s. The company has a team that has done it before completed with highly skilled subject experts in the field and has launched 3 products laying the foundations for this project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HOLOCYT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HOLOCYT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More